GSK to Produce 1 Billion Doses of Coronavirus Vaccine Booster in 2021

General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 4, 2020. REUTERS/Matthew Childs

General view outside GlaxoSmithKline (GSK) headquarters in Brentford, following the outbreak of the coronavirus disease (COVID-19), London, Britain, May 4, 2020. REUTERS/Matthew Childs

GSK is one of several companies in the race to develop a vaccine for the respiratory illness that currently has no treatment and has already killed about 350,000 people.

  • Reuters
  • Last Updated: May 28, 2020, 12:49 PM IST

GlaxoSmithKline Plc will expand production of vaccine efficacy boosters, or adjuvants, to produce 1 billion doses in 2021 for use in shots for COVID-19, the British drugmaker said on Thursday.

The London-listed company said it was in talks with governments on backing for the programme, which would effectively allow for a scaling up of production of future successful vaccines for the disease caused by the novel coronavirus.

GSK is one of several companies in the race to develop a vaccine for the respiratory illness that currently has no treatment and has already killed about 350,000 people.

The British drugmaker is working on its own COVID vaccine with Sanofi .

Adjuvants have been shown to create a stronger and longer-lasting immunity against infections.

GSK’s adjuvant can reduce the amount of vaccine protein required per dose, which would allow for more vaccines to be made, the British drugmaker said.

Experts have predicted that a successful vaccine will take over a year to develop, and companies and governments are pouring money into dozens of programmes as the only viable solution that will allow the world to escape durably from coronavirus lockdowns and get economies moving again.







https://pubstack.nw18.com/pubsync/fallback/api/videos/recommended?source=n18english&channels=5d95e6c378c2f2492e2148a2&categories=5d95e6d7340a9e4981b2e10a&query=GSK,to,Produce,1,Billion,Doses,of,Coronavirus,Vaccine,Booster,in,2021,coronavirus,coronavirus,vaccine,&publish_min=2020-05-26T23:20:25.000Z&publish_max=2020-05-28T23:20:25.000Z&sort_by=date-relevance&order_by=0&limit=2

Next Story

[ad_2]

Source link

About the author: Sohom Das
Founder of Tuccho.
We will be happy to hear your thoughts

      Get involved!

      Get Connected!

      Come and join our community marketplace. Expand your network, get to know new people and start earning!

      Comments

      No comments yet
      Tuccho
      Logo
      Register New Account
      Reset Password
      Compare items
      • Total (0)
      Compare
      0